Allergan’s Vice President of Investor Relations, Lisa DeFrancesco, has left after nearly 8 years of leading the Investor Relations of the drugmaker.
Lisa DeFrancesco
After leading the Allergan’s Investor Relations during the transformation from Watson to Actavis and finally to Allergan, DeFrancesco said that she has decided that “now is the right time to pursue other career opportunities”
The company said it has started an executive search to fill the position. DeFrancesco will stay with the company until a successor is named to ensure a smooth transition, Allergan said.